Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.305\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CC1(C)CC(=O)C=C(Nc2ccc(Cl)c(Br)c2)C1
b. Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccc(Cl)cc2Cl)c1CN1CCCCC1
c. CNS(=O)(=O)c1cn(CC(=O)N(C)Cc2ccccc2)cc1S(=O)(=O)NC
Answer: c. CNS(=O)(=O)c1cn(CC(=O)N(C)Cc2ccccc2)cc1S(=O)(=O)NC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CNS(=O)(=O)c1cn(CC(=O)N(C)Cc2ccccc2)cc1S(=O)(=O)NC
CNS(=O)(=O)c1cn(CC(=O)N(C)Cc2ccccc2)cc1S(=O)(=O)NC
N-benzyl-2-[3,4-bis(methylsulfamoyl)pyrrol-1-yl]-N-methylacetamide